FDA Inspection
Pfizer Inc.Pfizer Inc. – FDA Inspection, Aug 10, 2009
Record Details
This FDA Inspection record concerns Pfizer Inc., with an inspection on August 10, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pfizer Inc.
- Inspection Date
- August 10, 2009
- Product Type
- Drugs
View Company Profile
ID · be0b721d-2553-4d74-aa0d-fe8c2d5d6343
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 606526
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Pfizer Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 22, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 26, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 15, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 6, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Pfizer Inc.
- FDA Inspection 1176364 - 2022-07-22
- FDA Inspection 946884 - 2015-08-26
- FDA Inspection 805292 - 2012-10-15
- FDA Inspection 785976 - 2012-06-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.